£48.33

CRC Press Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

Price data last checked 109 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£48 today · previous high £48 · all-time low £44

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 622 days • 622 data points (No recent data available)

Historical
Generating forecast...
£48.33 £43.13 £44.26 £45.40 £46.53 £47.67 £48.80 09 June 2024 11 November 2024 15 April 2025 17 September 2025 20 February 2026

Price Distribution

Price distribution over 622 days • 3 price levels

Days at Price
Current Price
305 days 294 days 23 days · current 0 76 153 229 305 £44 £46 £48 Days at Price

Price Analysis

Most common price: £44 (305 days, 49.0%)

Price range: £44 - £48

Price levels: 3 different prices over 622 days

Description

State-of-the-Art Methods for Drug Safety Assessment Responding to the increased scrutiny of drug safety in recent years, Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting explains design, monitoring, analysis, and reporting issues for both clinical trials and observational studies in biopharmaceutical product development. It presents the latest statistical methods for drug safety assessment. The book’s three sections focus on study design, safety monitoring, and data evaluation/analysis. The book addresses key challenges across regulatory agencies, industry, and academia. It discusses quantitative approaches to safety evaluation and risk management in drug development, covering Bayesian methods, effective safety graphics, and risk-benefit evaluation. Written by a team of experienced leaders, this book brings the most advanced knowledge and statistical methods of drug safety to the statistical, clinical, and safety community. It shares best practices and stimulates further research and methodology development in the drug safety area.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)
99% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£85.00 08 Mar 2026
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
97% match

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£44.44 21 Feb 2026
Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches (Chapman & Hall/CRC Biostatistics Series)
97% match

Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£93.00 25 Jan 2026
Specification of Drug Substances and Products: Development and Validation of Analytical Methods
97% match

Specification of Drug Substances and Products: Development and Validation of Analytical Methods

Elsevier

£24.15 07 Feb 2026
Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing (Chapman & Hall/CRC Biostatistics Series)
97% match

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£86.76 27 Feb 2026
Adaptive Design Theory and Implementation Using SAS and R (Chapman & Hall/CRC Biostatistics Series)
97% match

Adaptive Design Theory and Implementation Using SAS and R (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£62.93 23 Jan 2026
Adaptive Design Theory and Implementation Using SAS and R (Chapman & Hall/CRC Biostatistics Series)
97% match

Adaptive Design Theory and Implementation Using SAS and R (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£120.00 09 Dec 2025
Cross-over Trials in Clinical Research: 5 (Statistics in Practice)
97% match

Cross-over Trials in Clinical Research: 5 (Statistics in Practice)

Wiley

£94.99 08 Jan 2026
Cobert's Manual Of Drug Safety And Pharmacovigilance (Fourth Edition): 4th Edition
97% match

Cobert's Manual Of Drug Safety And Pharmacovigilance (Fourth Edition): 4th Edition

£49.00 08 Jan 2026
Statistical Methods in Biomarker and Early Clinical Development
97% match

Statistical Methods in Biomarker and Early Clinical Development

£104.17 12 Jan 2026
Statistical Methods in Biomarker and Early Clinical Development
97% match

Statistical Methods in Biomarker and Early Clinical Development

Springer

£105.00 09 Mar 2026
Statistical Thinking for Non-Statisticians in Drug Regulation
97% match

Statistical Thinking for Non-Statisticians in Drug Regulation

Wiley-Blackwell

£60.99 25 Jan 2026
Statistics in Drug Research: Methodologies and Recent Developments
97% match

Statistics in Drug Research: Methodologies and Recent Developments

CRC Press

£63.94 08 Mar 2026
Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)
96% match

Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£62.35 02 Mar 2026
Statistical Methods in Healthcare
96% match

Statistical Methods in Healthcare

Wiley

£86.48 20 Feb 2026
Pharmaceutical Experimental Design (Drugs and the Pharmaceutical Sciences)
96% match

Pharmaceutical Experimental Design (Drugs and the Pharmaceutical Sciences)

CRC Press

£62.24 26 Feb 2026
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
96% match

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£119.60 23 Feb 2026
Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)
96% match

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£141.70 08 Feb 2026
Statistics in Drug Research: Methodologies and Recent Developments: 10 (Chapman & Hall/CRC Biostatistics)
96% match

Statistics in Drug Research: Methodologies and Recent Developments: 10 (Chapman & Hall/CRC Biostatistics)

CRC Press

£239.20 10 Jan 2026
Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)
96% match

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£42.31 28 Feb 2026
Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)
96% match

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Springer

£118.95 24 Feb 2026
Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)
96% match

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Springer

£124.39 22 Jan 2026
Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis: 91 (Chapman & Hall/CRC Biostatistics Series)
96% match

Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis: 91 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£46.45 22 Feb 2026
Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)
96% match

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£45.07 07 Mar 2026